Scynexis Names Sanjay Subramanian CFO
(RTTNews) - Scynexis Inc. (SCYX), a clinical-stage biotechnology company focused on severe rare diseases, on Thursday appointed Sanjay Subramanian as Chief Financial Officer, effective September 9.
The company also announced the retirement of Ivor Macleod as CFO, on the same date.
Macleod will remain with the company through October 9 to support the transition.
Subramanian has more than 20 years of experience and most recently served as CFO and Head of Business Development at Inozyme Pharma.
On Wednesday, Scynexis closed trading 4.66% lesser at $4.9100 on the Nasdaq.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.